Similar metabolic response to animal, plant protein diets

Similar metabolic response to animal, plant protein diets

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), isocaloric diets high in animal protein (AP) or plant protein (PP) are associated with similar improvements in metabolism and cardiovascular risk factors, according to a study published online Feb. 9 in Diabetes, Obesity and Metabolism.

Stephanie Sucher, from the German Institute of Human Nutrition Potsdam-Rehbruecke in Nuthetal, and colleagues compared diets differing in amino acid composition in 44 patients with T2DM. Isocaloric diets containing 30 percent of energy as AP or PP, combined with 30 percent fat and 40 percent carbohydrates, were compared in a randomized parallel group study.

The researchers observed significant decreases in uric acid in both groups, but significantly more in AP versus PP. There were significant improvements in hemoglobin A1c, diastolic blood pressure, and fasting non-esterified fatty acids in PP but not AP. There were significant improvements in AP but not PP for insulin sensitivity, C-reactive protein, and fasting glucose. In both groups, total and decreased significantly, and there was a decrease from baseline in urinary albumin excretion rate in microalbuminuric subjects.

"Isocaloric diets high in animal or allow similar improvements of metabolism and in T2DM patients indicating that the differences in do not affect the metabolic responses to the interventions," the authors write.

More information: Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Similar metabolic response to animal, plant protein diets (2017, February 13) retrieved 24 May 2024 from https://medicalxpress.com/news/2017-02-similar-metabolic-response-animal-protein.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Gemigliptin, metformin combo beats monotherapy in T2DM

0 shares

Feedback to editors